{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-003950","form_type":"8-K","ticker":"BTAI","cik":"0001720893","company_name":"BioXcel Therapeutics, Inc.","filed_at":"2025-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.583783+00:00","generated_at":"2026-05-28T00:09:46.024148+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"BioXcel Therapeutics appoints Dr. Rajiv Patni to Board of Directors","bullets":["Board increased from seven to eight directors on January 15, 2025.","Dr. Patni appointed as Class II director, term expiring at 2026 annual meeting.","He brings experience as CEO of Judo Bio and former CRO at Reata Pharmaceuticals.","Granted option to purchase 44,000 shares at $0.3465, vesting over three years.","Eligible for standard non-employee director compensation program."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-003950","json":"https://secwatch.observer/filing/0001104659-25-003950.json","markdown":"https://secwatch.observer/filing/0001104659-25-003950.md","text":"https://secwatch.observer/filing/0001104659-25-003950.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1720893/000110465925003950/0001104659-25-003950-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1720893/000110465925003950/tm253320d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T00:09:46.024148+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"09b9c5c0eb","claim":"Dr. Rajiv Patni was appointed as Director at BioXcel Therapeutics, Inc..","evidence_excerpt":"On January 15, 2025, the Board appointed Dr. Rajiv Patni to the Board, effective January 15, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465925003950/0001104659-25-003950-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}